Clinical Trial

Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled study will compare the effects of the ShotBlocker device and the Helfer Skin Tap Technique on pain and fear during intramuscular hormone injections in premenopausal and postmenopausal breast cancer patients. Ninety-nine participants will be randomly assigned to three groups (ShotBlocker, Helfer, control). All injections will be administered by the same nurse using standardized procedures. Pain will be assessed with the Visual Analog Scale, and fear with the Injection Fear Scale. The study aims to identify effective nonpharmacological methods to enhance patient comfort, support treatment adherence, and improve nursing care quality.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-05.
Trial Details
NCT Number NCT07406165
Lead Sponsor Inonu University
Conditions Breast Cancer, Pain Management, Fear, Injection Fear, Injection Pain Prevention
Enrollment 99 participants
Start Date 2026-02-10
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-13